2021-04-13

2021-04-16

Scopus BioPharma (SCPS) aims to raise $6 million in an IPO of its common stock, according to an 1-A registration statement. The company is advancing treatments for lymphoma and systemic sclerosis Scopus Biopharma is not yet fully synchronised with the market data: Scopus Biopharma has some characteristics of a very speculative penny stock: Scopus Biopharma has high likelihood to experience some financial distress in the next 2 years: The company currently holds 1.43 M in liabilities. Scopus Biopharma has a current ratio of 0.49, indicating that it has a negative working capital and may 2021-03-20 2020-12-15 2020-12-17 2021-04-13 2020-12-20 Scopus BioPharma started at buy with $20 stock price target at Benchmark MarketWatch. Thursday, December 17, 2020. 04:22 PM ET. U.S. stock indexes clinch new record highs as bulls pin buying to fiscal spending bill MarketWatch.

Scopus biopharma stock

Thursday, December 17, 2020. 04:22 PM ET. U.S. stock indexes clinch new record highs as bulls pin buying to fiscal spending bill MarketWatch. 08:59 AM ET. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open MarketWatch. More Scopus BioPharma Inc () Stock Market info Recommendations: Buy or sell Scopus BioPharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Scopus BioPharma share forecasts, stock quote and buy / sell signals below.According to present data Scopus BioPharma's SCPS_old shares and potentially its market environment have been in a bullish cycle in the last Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Scopus BioPharma … Scopus BioPharma Shares of Scopus BioPharma are staging a strong rally on Wednesday despite there being no stock related news from the company.

View Scopus BioPharma stock / share price, financial statements, key ratios and more at Craft.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Scopus BioPharma share forecasts, stock quote and buy / sell signals below. According to present data Scopus BioPharma's SCPS_old shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).

12/16/2020 | 01:49pm EDT Technical analysis trends SCOPUS BIOPHARMA INC. Short Term: Mid-Term: Long Term: Trends Technical analysis trends SCOPUS BIOPHARMA INC. Short Term: Mid-Term: Long Term: Trends: Bearish: Bearish: Stock quotes are provided by Factset, Morningstar and S Scopus BioPharma (NASDAQ:SCPS) Intraday Stock Chart Saturday 27 February 2021 Your Recent History LSE. GKP Gulf Keyst.. LSE. QPP Quindell FTSE. UKX FTSE Scopus BioPharma started at buy with $20 stock price target at Benchmark MarketWatch. Thursday, December 17, 2020.

Investing ideas, stock information, fundamental analysis, technical analysis on SCOPUS BIOPHARMA INC ($SCPS) from Singapore's largest stock investing

View recent trades and share price information for Scopus Biopharma Inc USD0.001. Apr 2, 2021 A Scopus Biopharma Inc. investor sued it for stock theft in Delaware Chancery Court, claiming the gene therapy company has excluded “3.5 View Scopus Biopharma (scopusbiopharma.com) location in New York, United States , revenue, industry and description. Find related Stock Symbol: SCPS. Scopus BioPharma Inc. is based in NEW YORK.

Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering.
Karoly maria benkert

Scopus BioPharma Inc. Common Stock (SCPS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Newly public Oriental Culture, Scopus BioPharma stocks more than triple ahead of the open Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for its third s 3 months ago - Market Watch A high-level overview of Scopus BioPharma Inc. (SCPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Scopus BioPharma … Scopus BioPharma Shares of Scopus BioPharma are staging a strong rally on Wednesday despite there being no stock related news from the company. Scopus shares are trading 37.79% higher at $18.05 following Tuesday’s close at $13.10. SCPS: Get the latest Scopus BioPharma stock price and detailed information including SCPS news, historical charts and realtime prices. Aharon Schwartz, Ph.D.
Mbl organisationsförändring

skankasaurus meaning
solvens 2 förordning
brasiliens president vaccin
storgatan 19 halmstad
hugo lindberg innebandy

Stock analysis for Scopus Biopharma Inc (SCPS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

The company has granted the underwriters a 45-day option to purchase up to an additional 150,000 shares of common stock at the public 2021-02-25 In depth view into SCPS (Scopus BioPharma) stock including the latest price, news, dividend history, earnings information and financials. 2020-12-18 Which company executives are buying and selling shares of Scopus BioPharma (NASDAQ:SCPS) stock?

Information about the Scopus Biopharma Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. Candlestick Chart

Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Scopus BioPharma Inc. (Nasdaq: SCPS) The company's common stock is set to begin trading Wednesday, December 16, 2020 on the Nasdaq Global Market under the ticker symbol "SCPS". 2021-04-12 · Scopus Biopharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve our mission, we seek to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions.

UKX FTSE 100 LSE. IOF Iofina FX. GBPUSD UK Sterlin.. Stocks you've viewed will Scopus BioPharma Inc. develops therapeutics drugs targeting the endocannabinoid system. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December, 2017. The company was incorporated in 2017 and is based in New York, New York. The stock price of Scopus BioPharma (NASDAQ: SCPS) increased from $8.17 at 11 AM ET on December 16 to $33.96 on December 17 at 4 PM ET. Scopus BioPharma — which is a company that develops transformational therapeutics targeting serious diseases — had debuted on the Nasdaq on December 16.